- DexCom (DXCM) shares have put together an encouraging short-term bounce as the company maps out a multi-year growth algorithm.
- The stock currently carries a 8% “Sell” rating, but that’s up from the prior day’s 96% “Sell” rating and 100% “Sell” last week. A positive trend on that indicator.
- DXCM is building near-term upside strength, following its 2026 Investor Day strategy presentation last week.
- Despite a steep winter drawdown that left the stock more than 50% below its 2024 high, and about 60% below its 2021 all-time high, a constructive base is forming well above its $56 multi-year low.